Assessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99–411, with long acting prescription antimalarials, lumefantrine and piperaquine

The pharmacokinetic compatibility of short-acting CDRI candidate antimalarial trioxane derivative, 99–411, was tested with long-acting prescription antimalarials, lumefantrine and piperaquine. LC-ESI-MS/MS methods were validated for simultaneous bioanalysis of lumefantrine and 99–411 and of piperaqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Taneja, Isha, Raju, Kanumuri Siva Rama, Singh, Sheelendra Pratap, Wahajuddin, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658560/
https://www.ncbi.nlm.nih.gov/pubmed/26602250
http://dx.doi.org/10.1038/srep17264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658560/
https://www.ncbi.nlm.nih.gov/pubmed/26602250
http://dx.doi.org/10.1038/srep17264

Ejemplares similares